We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Bioquell | LSE:BQE | London | Ordinary Share | GB0004992003 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 597.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMBQE
RNS Number : 5405M
Bioquell PLC
30 April 2018
RNS announcement 30 April 2018
Bioquell PLC
("Bioquell", or "the Company")
Purchase of own shares
The Company announces that on 26 April 2018 it purchased 33,00 of its ordinary shares on the London Stock Exchange at a price of 300 pence per share. The purchased shares will be cancelled.
Aggregated information:
Date of purchase: 27 April 2018 Number of ordinary shares purchased: 33,000 Volume weighted average price paid 300 pence per share: Transaction details: Issuer name: Bioquell Plc ISIN: GB0004992003 Timezone: GMT Currency: GBP
Total Number of Voting Rights
In accordance with DTR 5.6.1 of the FCA's Disclosure Guidance and Transparency Rules, the Company is required to notify the market of the total number of voting rights and capital in the Company as at the end of each calendar month in which an increase or decrease has occurred.
The issued share capital of the Company is comprised of 23,087,017 ordinary shares of 10p each. As 797,000 of these ordinary shares are held as treasury shares, the total number of voting rights in the Company is 22,290,017. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
Hot Features
Premium
Bioquell PLC Tel: +44 (0)1264 835800
Ian Johnson, Executive Chairman
Michael Roller, Finance Director
N+1 Singer Tel: +44 (0) 20 7496
3000
Mark Taylor / James White
This information is provided by RNS
The company news service from the London Stock Exchange
END
POSFMGFDRGFGRZG
(END) Dow Jones Newswires
April 30, 2018 04:36 ET (08:36 GMT)
1 Year Bioquell Chart |
1 Month Bioquell Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
